title: Myeloma and thrombotic complications.
abstract: Multiple myeloma (MM) is a hematological malignancy with high risk for thrombosis. While venous thromboembolism is more common, myeloma patients can also present with arterial thrombosis. Risk factors responsible for this complication can be patient-related, myeloma- and treatment-related. Thromboprophylaxis is indicated along with specific therapeutic regimens employed in myeloma patients. This review will cover potential risk factors for thrombosis in patients with multiple myeloma, prevention recommendations and treatment strategies in this clinical setting.
authors.affiliation: Department of Hematology and Bone Marrow Transplantation Rambam Health Care Campus, Haifa, Israel.
authors.forename: I
authors.initials: I
authors.lastname: Tzoran
authors.forename: B
authors.initials: B
authors.lastname: Brenner
authors.forename: R
authors.initials: R
authors.lastname: Hoffman
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D006801:Humans; D009101:Multiple Myeloma / Q000097:blood / Q000150:complications*; D013927:Thrombosis / Q000097:blood / Q000209:etiology* / Q000517:prevention & control; D054556:Venous Thromboembolism / Q000097:blood / Q000209:etiology / Q000517:prevention & control
chemical_list: D000925:Anticoagulants